Please use this identifier to cite or link to this item:
|Title:||Transport of thalidomide by the human intestinal Caco-2 monolayers||Authors:||Zhou, S.
|Issue Date:||Jan-2005||Citation:||Zhou, S.,Li, Y.,Kestell, P.,Schafer, P.,Chan, E.,Paxton, J.W. (2005-01). Transport of thalidomide by the human intestinal Caco-2 monolayers. European Journal of Drug Metabolism and Pharmacokinetics 30 (1-2) : 49-61. ScholarBank@NUS Repository.||Abstract:||Studies in patients have indicated that the oral absorption of thalidomide is considerably variable at high doses (>200 mg/day). The aim of this study was to investigate the transport of racemic thalidomide using human colon cancer cell line (Caco-2) monolayers, which have been widely used to investigate drug permeability. A typical 21-day protocol was used to prepare Caco-2 monolayers. Thalidomide was determined by a validated high performance liquid chromatography method with ultraviolet detection. The integrity of Caco-2 monolayer was confirmed when the transepithelial electrical resistance (TEER) exceeded 300 Ω · cm2, and the leakage of 14C-manitol was||Source Title:||European Journal of Drug Metabolism and Pharmacokinetics||URI:||http://scholarbank.nus.edu.sg/handle/10635/106468||ISSN:||03787966|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 13, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.